FDA 483 OBSERVATION · #765 OF 1,932 MOST-CITED

SOPs for investigations, records

FDA cited this observation 26 times across 26 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

What this grouping is not

An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.

BY PROGRAM AREA
Biologics26
BY FISCAL YEAR
FY20256
FY20241
FY20233
FY20221
FY20194
FY20182
FY20176
FY20163

How FDA worded it — real examples

Written standard operating procedures for all steps in the investigation of product deviations under the regulations and recordkeeping related to current good manufacturing practice and other applicable requirements and standards were not established, maintained, followed and available to personnel in the areas where procedures were performed.

Emerson Health Hospital · Concord, Massachusetts · Biologics · 2025-08-06

Written standard operating procedures for all steps in the investigation of product deviations under the regulations and recordkeeping related to current good manufacturing practice and other applicable requirements and standards were not established, maintained and followed.

Fargo VA Healthcare System · Fargo, North Dakota · Biologics · 2025-06-13

Written standard operating procedures for all steps in recordkeeping related to current good manufacturing practice and other applicable requirements and standards were not followed.

Valley Health System Hospital Laboratory Services · Las Vegas, Nevada · Biologics · 2025-04-03

Written standard operating procedures for all steps in the investigation of product deviations under the regulations were not established.

Ioannis Lougaris VA Medical Center Laboratory Service (113) Blood Bank · Reno, Nevada · Biologics · 2025-02-28

Written standard operating procedures for all steps in the investigation of product deviations under the regulations were not established, maintained and followed.

Memorial Hospital For Cancer & Allied Diseases · New York, New York · Biologics · 2025-02-13

Written standard operating procedures for all steps in the investigation of product deviations under the regulations were not followed.

Stanford Blood Center · Palo Alto, California · Biologics · 2024-11-26

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Quality risk management →Biologics industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →